| 36482 | In this procedure, the provider inserts a chemical adhesive through a catheter into an incompetent vein in an extremity to ablate the vein. The provider reports this code for treatment of the first… | 90 | $1,310 | $111.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,160 | $90 | $105.8K |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 220 | $330 | $73.9K |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 410 | $130 | $51.5K |
| 33285 | The provider inserts a cardiac rhythm monitor with self–contained electrodes into a pocket in the tissues beneath the patient's skin and programs the device according to manufacturer’s directions. | 30 | $1,790 | $48.4K |
| J2785 | Injection, regadenoson, 0.1 mg | 890 | $40 | $37.5K |
| 36465 | In this procedure, the provider injects a noncompounded foam sclerosing solution into a single incompetent truncal vein of the extremity under ultrasound guidance to guide the dispersion of foam,… | 30 | $1,010 | $34.3K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 450 | $80 | $33.6K |
| 93229 | In this procedure, the provider, typically a technician, places a wearable electrocardiographic monitoring device on the patient, instructs him in its use, and monitors the transmissions, to detect… | 50 | $650 | $33.6K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 230 | $90 | $21K |